Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Adds Nine Startups to Accelerator Program, Announces £20M Matching Fund

NEW YORK – Illumina announced Monday the funding of nine companies as part of its accelerator programs in the US and the UK.

During the six-month funding cycle, the participants will receive an undisclosed amount of seed investment, access to Illumina sequencing systems and reagents, and lab space adjacent to Illumina's Bay Area and Cambridge, UK campuses, respectively, as well as access to guidance and expertise.

Illumina also announced it has secured £20 million ($27.5 million) in commitments that would match between £500,000 and £4 million in new capital raised by Illumina Accelerator Cambridge graduates within a year. The funding includes £10 million from LifeArc.

The new cohort includes several firms developing diagnostics or genomics tools.

BiotaX Labs, a spinoff of Israel's Technion Research and Development Foundation, is focusing on microbiome-based diagnostics and treatments.

Broken String Biosciences, from Cardiff, UK, is developing a platform of novel sequencing tools to assess genome stability.

MultiplAI Health, a diagnostics company with roots in London and Buenos Aires is leveraging advances in genomics and artificial intelligence to develop universal remote screening for cardiovascular diseases.

Oshun Medical, a diagnostics company from the Bay Area focusing on women's health, is working to predict pregnancy complications.

Illumina Accelerator has invested in more than 45 genomics startups from across the globe, which have collectively raised nearly $600 million in venture capital funding. Last month, Illumina announced it would be partnering with Sequoia Capital China on a genomics incubator in China.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.